Correlation Between Eupraxia Pharmaceuticals and Zenas BioPharma,
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and Zenas BioPharma, Common, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Zenas BioPharma,.
Diversification Opportunities for Eupraxia Pharmaceuticals and Zenas BioPharma,
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Eupraxia and Zenas is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Zenas BioPharma, go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Zenas BioPharma,
Given the investment horizon of 90 days Eupraxia Pharmaceuticals Common is expected to generate 0.43 times more return on investment than Zenas BioPharma,. However, Eupraxia Pharmaceuticals Common is 2.34 times less risky than Zenas BioPharma,. It trades about 0.15 of its potential returns per unit of risk. Zenas BioPharma, Common is currently generating about -0.17 per unit of risk. If you would invest 300.00 in Eupraxia Pharmaceuticals Common on October 20, 2024 and sell it today you would earn a total of 20.00 from holding Eupraxia Pharmaceuticals Common or generate 6.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals Commo vs. Zenas BioPharma, Common
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
| Zenas BioPharma, Common |
Eupraxia Pharmaceuticals and Zenas BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Zenas BioPharma,
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.| Eupraxia Pharmaceuticals vs. Gladstone Investment | Eupraxia Pharmaceuticals vs. Sun Life Financial | Eupraxia Pharmaceuticals vs. Beauty Health Co | Eupraxia Pharmaceuticals vs. East West Bancorp |
| Zenas BioPharma, vs. Dogwood Therapeutics, | Zenas BioPharma, vs. Eupraxia Pharmaceuticals Common | Zenas BioPharma, vs. CERo Therapeutics Holdings | Zenas BioPharma, vs. Opus Genetics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |